Back to Research Hub
Johnson & Johnson
JNJ
$237.00+4.84 (+2.08%)
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc.
StreetsValue research for Johnson & Johnson (JNJ)
Members get the full report for Johnson & Johnson: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.